Cargando…

Hamlet’s augury: how to manage discontinuation of mood stabilizers in bipolar disorder

Research has generated good quality evidence about the treatment and management of bipolar disorder in acute and, to some degree, sub-acute/continuation phases. This has informed various guidelines about the treatment and management of bipolar disorder (BD). However, for the long-term or maintenance...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qureshi, Mutahira M., Young, Allan H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2021
Materias:	Discontinuing Psychotropic Medications
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7968017/ https://www.ncbi.nlm.nih.gov/pubmed/33796268 http://dx.doi.org/10.1177/20451253211000612

Ejemplares similares

Barriers to discontinuing antidepressants in patients with depressive and anxiety disorders: a review of the literature and clinical recommendations
por: Scholten, Willemijn, et al.
Publicado: (2020)

Clozapine discontinuation withdrawal symptoms in schizophrenia
por: Blackman, Graham, et al.
Publicado: (2021)

Conversations with clients about antidepressant withdrawal and discontinuation
por: Karter, Justin M.
Publicado: (2020)

Barriers to stopping neuroleptic (antipsychotic) treatment in people with schizophrenia, psychosis or bipolar disorder
por: Moncrieff, Joanna, et al.
Publicado: (2020)

Experiences with benzodiazepine use, tapering, and discontinuation: an Internet survey
por: Reid Finlayson, Alistair J., et al.
Publicado: (2022)

Patients’ attitudes to discontinuing not-indicated long-term antidepressant use: barriers and facilitators
por: Eveleigh, Rhona, et al.
Publicado: (2019)

Polypharmacy-induced cognitive dysfunction and discontinuation of psychotropic medication: a neuropsychological case report
por: Valtonen, Jussi, et al.
Publicado: (2020)

Clinical practice guideline recommendations on tapering and discontinuing antidepressants for depression: a systematic review
por: Sørensen, Anders, et al.
Publicado: (2022)

How user knowledge of psychotropic drug withdrawal resulted in the development of person-specific tapering medication
por: Groot, Peter C., et al.
Publicado: (2020)

How effective are antidepressants for depression over the long term? A critical review of relapse prevention trials and the issue of withdrawal confounding
por: Hengartner, Michael P.
Publicado: (2020)

May antidepressant drugs worsen the conditions they are supposed to treat? The clinical foundations of the oppositional model of tolerance
por: Fava, Giovanni A.
Publicado: (2020)

The ‘patient voice’: patients who experience antidepressant withdrawal symptoms are often dismissed, or misdiagnosed with relapse, or a new medical condition
por: Guy, Anne, et al.
Publicado: (2020)

What it was like to stop an antidepressant
por: Stockmann, Tom
Publicado: (2019)

Withdrawal effects confounding in clinical trials: another sign of a needed paradigm shift in psychopharmacology research
por: Cohen, David, et al.
Publicado: (2020)

Protracted withdrawal syndrome after stopping antidepressants: a descriptive quantitative analysis of consumer narratives from a large internet forum
por: Hengartner, Michael P., et al.
Publicado: (2020)

Service-user efforts to maintain their wellbeing during and after successful withdrawal from antipsychotic medication
por: Larsen-Barr, Miriam, et al.
Publicado: (2021)

What I have learnt from helping thousands of people taper off antidepressants and other psychotropic medications
por: Framer, Adele
Publicado: (2021)

Prophylactic effects or withdrawal reactions? An analysis of time-to-event data from antidepressant relapse prevention trials submitted to the FDA
por: Hengartner, Michael P., et al.
Publicado: (2021)

Enduring neurological sequelae of benzodiazepine use: an Internet survey
por: Huff, Christy, et al.
Publicado: (2023)

Outcomes of hyperbolic tapering of antidepressants
por: van Os, Jim, et al.
Publicado: (2023)

Overdose and off-label psychotropic prescribing in patients with borderline personality disorder: A retrospective series
por: Ning, Anna Y, et al.
Publicado: (2023)

The prescription of psychedelic therapies in Australia and New Zealand: A brief survey of psychiatrists
por: Berger, Joshua J, et al.
Publicado: (2023)

The parable of the Therapeutic Goods Administration approval of esketamine (Spravato) in Australia
por: Lugg, William
Publicado: (2023)

Tanti auguri World Wide Web
Publicado: (2009)

Telegramma di auguri per il dissidente Orlov
Publicado: (1977)

Pharmacogenomics of Mood Stabilizers in the Treatment of Bipolar Disorder
por: Squassina, Alessio, et al.
Publicado: (2010)

Therapeutic monitoring of mood stabilizers in bipolar disorder
por: Falfel, D., et al.
Publicado: (2021)

Trajectories of adherence to mood stabilizers in patients with bipolar disorder
por: Bauer, M., et al.
Publicado: (2019)

RNA Biomarkers in Bipolar Disorder and Response to Mood Stabilizers
por: Pisanu, Claudia, et al.
Publicado: (2023)

Effectiveness of mood stabilizers in prophylactic treatment of bipolar disorder
por: Khattech, D., et al.
Publicado: (2023)

Mood Stabilisers, but for Lithium, are not stabilizing Moods! Bipolar Disorders: Clinical conundrums 2
por: Reddy, M. S., et al.
Publicado: (2017)

SN algorithm: analysis of temporal clinical data for mining periodic patterns and impending augury
por: Sengupta, Dipankar, et al.
Publicado: (2013)

Management of bipolar depression with lamotrigine: an antiepileptic mood stabilizer
por: Prabhavalkar, Kedar S., et al.
Publicado: (2015)

Hamlet
por: Shakespeare, William, 1564-1616
Publicado: (2003)

The hamlet /
por: Faulkner, William, 1897-1962
Publicado: (1940)

Hamlet
por: Doyle, Patrick, 1953-
Publicado: (2007)

Hamlet
por: Shakespeare, William, 1564-1616
Publicado: (1988)

Hamlet /
por: Shakespeare, William, 1564-1616
Publicado: (1989)

Hamlet /
Publicado: (1963)

Hamlet
por: Shakespeare, William, 1564-1616
Publicado: (1971)

Cannot write session to /tmp/vufind_sessions/sess_n3tilbpsc3a40pnktciahj35aj